Overview
Kausar Jabbar is a Medical Genetics provider practicing medicine in Troy,, Michigan.
Her clinical expertise encompasses Myeloproliferative Neoplasms (MPN).
She is actively involved in clinical research, co-authoring 16 peer reviewed articles. Dr. Jabbar is currently accepting new patients.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- PPO
Locations
44201 Dequindre Rd, Troy,, MI 48085
3601 W 13 Mile Rd, Royal Oak, MI 48073
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
University Of Michigan Pediatric Genetics Clinic
Donna Martin is a Medical Genetics specialist and a Pediatrics provider practicing medicine in Ann Arbor, Michigan. Dr. Martin is highly rated in 1 condition, according to our data. Her clinical expertise encompasses CHARGE Syndrome and Neurofibromatosis Type 1 (NF1). Dr. Martin is board certified in American Board Of Medical Genetics And Genomics, Clinical Biochemical Genetics - 2023. Dr. Martin is currently accepting new patients.
Kirit Pindolia is a Medical Genetics provider practicing medicine in Canton, Michigan. Dr. Pindolia is highly rated in 1 condition, according to our data. His clinical expertise encompasses Biotinidase Deficiency.
Kristin Monaghan is a Medical Genetics provider practicing medicine in Detroit, Michigan. Dr. Monaghan is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses Hypotonia, Early Infantile Epileptic Encephalopathy, 1p36 Deletion Syndrome, and Microcephaly Deafness Syndrome.
Frequently Asked Questions about Dr. Kausar J. Jabbar
How do I make an appointment with Dr. Kausar J. Jabbar?
You can book an appointment with Dr. Kausar J. Jabbar by calling their office at 248-964-4100. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Kausar J. Jabbar a top-rated expert for Myeloproliferative Neoplasms (MPN)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Kausar J. Jabbar is classified as an Experienced expert for Myeloproliferative Neoplasms (MPN), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Kausar J. Jabbar specialize in?
While Dr. Kausar J. Jabbar is a Medical Genetics, they have specific expertise in Myeloproliferative Neoplasms (MPN). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Medical Genetics.
Does Dr. Kausar J. Jabbar participate in research or clinical trials?
Yes. Dr. Kausar J. Jabbar has published 16 articles and abstracts on conditions like Myeloproliferative Neoplasms (MPN). You can view a list of Dr. Kausar J. Jabbar's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Kausar J. Jabbar accept my insurance?
Dr. Kausar J. Jabbar accepts most major insurance plans, including Cigna. We recommend calling the office directly at 248-964-4100 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Myeloproliferative Neoplasms (MPN)Dr. Jabbar isExperienced. Learn about Myeloproliferative Neoplasms (MPN).